Mylan beats Street's estimates with Q3 earnings and beats Perrigo in effort to derail tender

Mylan ($MYL) has swept aside one of the legal hurdles set up by Perrigo ($PRGO), which has been fighting on two continents to try to derail Mylan's takeover of the generics competitor. Mylan said today that a U.S. federal court ruled it has provided adequate explanations about the cost savings from combining the two companies, denying Perrigo's request for a temporary injunction. Perrigo also has an action pending in a court in Israel, where Perrigo's shares are listed. The win came as Mylan posted Q3 earnings of $1.43 per share, exceeding analyst projections of $1.38 per share. Earnings release | Court ruling release | More